Sentence examples for not for intermediate from inspiring English sources

For small positive the stratification design is optimal for very small and very large but not for intermediate effect sizes: If both and are small, the power of both the enrichment and the stratification design is close to the significance level, but the stratification design leads to a larger gain.

Of course, these values are not accessible for intermediate stages.

It was found that the Cb factor and moment resistance curve given by AISC-LRFD in Specification for structural steel buildings [2] are not accurate for intermediate (inelastic) and short plastic DHFBs leading to an unconservative design.

Furthermore, boundary effects are not seen for intermediate to high spatial resolutions and remain limited for h = 0.05 cm.

(8) The mortality data within 1 month by Foster et al. [ 7] should have been included in the subanalysis for perioperative mortality, not that for intermediate followup.

Conclusions Carotid endarterectomy was found to be superior to carotid artery stenting for short term outcomes but the difference was not significant for intermediate term outcomes; this difference was mainly driven by non-disabling stroke.

For example, in the observed data for hg O3e, the homoallelic combinations are seen for alleles 12, 13, 14, 18, and 19, but not for the intermediate alleles 15, 16, and 17; in the simulated data, the intermediates always appear.

For example, significant adaptation was indicated when the A allele reduced establishment for the x = 0.1 and 0.3 flocks but not for the intermediate x = 0.2 flock.

In other words, evolution is selecting for the (functional) product and not for an intermediate step, so an initial RNA-based network could not have come into place one reaction at a time, but only as an already operational entity.

Although there was an overall benefit on mortality (OR 0.52, 95% CI 0.36 to 0.74; P = 0.003), subgroup analyses revealed that mortality benefit was seen only in studies that included extremely high risk patients (OR 0.20, 95% CI 0.09 to 0.41; P < 0.0001) but not for the intermediate-risk patients (OR 0.83, 95% CI 0.41 to 1.69; P = 0.62).

The synergistic combination of the distinctive properties of the two separate phases dramatically enhances the ORR kinetics, which is attractive not only for intermediate-temperature SOFCs but also for other types of energy conversion and storage systems, including electrolysis cells and membrane reactors for synthesis of clean fuels.